Introduction
============

Ambidensoviruses belong to the *Parvoviridae* family, a group of small, non-enveloped viruses with icosahedral symmetry and a linear genome of 4--6 kb single-stranded (ss) DNA. *Parvoviridae* are divided into two subfamilies, depending upon whether they infect vertebrates (*Parvovirinae*), or invertebrates (*Densovirinae*, DNV). The latter currently include 15 virus species, divided into five genera, *Ambidensovirus*, *Brevidensovirus*, *Hepandensoviruses*, *Iteradensovirus* and *Penstyldensovirus (*[@ref-39]*)* even if that classification will probably be modified after the finding of echinoderm-infecting "densoviruses" ([@ref-41]). DNVs, like other members of the *Parvovirus* genus, are autonomously replicating viruses and differ in this respect from members of the genus *Dependoparvovirus* which need helper functions for replication. The DNV isolated from the lepidoptera *Junonia coenia* belongs to the species *Lepidopteran ambidensovirus* and will be named JcDV hereafter. JcDV (*Junonia coenia* densovirus, isolate Oxford, GenBank: [KC883978.1](KC883978.1)) has a 6,032 nucleotides genome with identical 547 nucleotides inverted terminal repeats (ITR). It exhibits an ambisense genomic organization, the non-structural (*NS*) and structural (*VP*) genes being positioned in the 5′-half of each complementary strand after conversion of the ss infectious genome in a double-stranded replicating genome. Each strand is encapsidated separately and converted into double-stranded DNA after infection ([@ref-15]). The JcDV genome ambisense organization displays a major open reading frame (ORF1) encoding four capsid proteins VP1 to VP4, the expression of which is under the control of the VP-gene cassette promoter, hereafter designated p9, on one strand ([@ref-36]), and three ORFs coding for replication proteins NS-1, NS-2 and NS-3 are located on the complementary strand and controlled by the NS-gene cassette promoter, traditionally designated p93 promoter ([@ref-36]). Those are translated from a 2.4 kb genomic mRNA (NS-3) and a sub-genomic 1.7 kb mRNA (NS-1 and NS-2) respectively ([@ref-36]).

The potential of *Densovirinae* as biocontrol agents against insect pests has been reported ([@ref-5]; [@ref-6]; [@ref-16]; [@ref-33]). Ambidensoviruses, as well as other members of the *Densovirinae* subfamily, have also been used as gene transfer vehicles to investigate viral pathogenesis and genetic manipulation of insects after integration of plasmidic ambidensovirus vectors either in vitro and in vivo ([@ref-2]; [@ref-7], [@ref-8]; [@ref-18]; [@ref-29]). On the other hand, dependoparvoviruses as well as *Rodent protoparvovirus 1* DNA molecules were shown to integrate in a foreign DNA after recognition, by the replication proteins, of precise binding and cutting sites shared between target genomic sequence and viral hairpins ([@ref-9]; [@ref-19]; [@ref-20]). Last, recent data show that a significant amount of *Parvoviridae* DNA remnants sign past infections, some of which gave rise to endogenization and expression of viral proteins ([@ref-23]). JcDV ITRs as well as non-structural protein 1 (NS1) activities resemble those of "integrative" *Parvovirinae* ([@ref-14]) and could explain the above mentioned integration events of plasmid DNA sequences in vitro and in vivo ([@ref-7], [@ref-8]; [@ref-29]).

In order to evaluate the capacity of linear JcDV sequences, more relevant to infectious viral genome, to integrate within the host DNA, different non-infectious linear constructs encompassing JcDV sequences were transfected into the non-permissive *Sf9* cell line. These constructs express the *green fluorescent protein* (GFP) gene under the control of the JcDV p9 promoter, which allowed us to follow the integration and expression of linear JcDV genes. In addition, our observations led us to investigate a possible role of JcDV NS proteins on the activity of the p9 promoter in vitro.

Altogether our results show that defined JcDV-derived sequences brought by linear DNA molecules are able to drive efficiently the integration and expression of a foreign gene into the genome of insect cells. We confirm that, as already described with circular plasmid vectors, some viral sequences---*i.e.*, ITRs and regulatory regions around the polyA signals---are indispensable for a correct expression of the transgene. Some viral integrated sequences as well as their flanking chromosomal regions were analyzed and were interpreted as a randomized integration within repeated or transposable elements (TE) and/or intergenic regions. Viral sequences show dramatic rearrangements in all cases and no complete viral genome was recovered from the integrated forms which were characterized. However, our results do not fully sustain the previous assessment that NS proteins expression favors integration at a low copy number in the host genome. In addition, a stable *NS* gene expression seems to be accompanied by a lower expression of the reporter gene. This result led us to evaluate in vitro a possible trans-regulation of the p9 promoter by the NS proteins, which does not seem to be the case. Our results led us to conclude that a recombinant JcDV virus encompassing only a transgene and an ITR could be sufficient as an integrative expression vector in insect cells.

Materials and Methods
=====================

Plasmids and derived linear molecules
-------------------------------------

Linear molecules were derived from already described JcDV-based plasmids, pJGFPH (pFull) encompassing an infectious sequence of the JcDV genome and pJGFPΔNSH (pVP) with deleted NS genes. For both plasmids the GFP coding sequence and simian virus 40 polyadenylation signal are inserted so as to place the *gfp* in frame, 25 codons downstream of the ATG initiation codon for VP4 polypeptide, under the transcriptional control of the P9 viral promoter ([@ref-7]). pHp9GFPNSH (pNS) vector displays the genuine *gfp* start codon 23 nucleotides downstream p9 TATA box.

For the measurement of the p9 promoter activity, the reporter plasmid (pHp9LUC-DNS) was obtained as follows: pFull was digested with *Nde*I then re-ligated to eliminate the p93 promoter and most of the NS proteins coding sequence. The *gfp* was then replaced with firefly luciferase gene (Luc), amplified from the pGL3 basic vector (Promega Madison, WI, USA) with the primers 5′-TGTTGGTAAAGCCACCATGGAAG-3′ (sense) and 5′-CTCGAAGCGGGCGGCCGCCCCGACTCTAG-3′ (antisense) using a high fidelity polymerase (Platinum Taq DNA Polymerase; Invitrogen, Courtaboeuf, France). A transfection control expressing the *Renilla reniformis* luciferase ([@ref-25]) under the control of the IE1 promoter of *Autographa californica Nucleopolyhedrovirus* (AcNPV) (kind gift of Just Vlak, Wageningen University, The Netherlands) was used as a "relative transfection control" of transduction efficiencies. Co-transfections were performed with JetPEI (Polyplus-Transfection, Illkirch, France) and luciferase activity was revealed using the Dual Luciferase Promoter Assay System (Promega, Madison, WI, USA) and quantified on a Berthold Centro LB 960 luminometer; Berthold Technologies, Thoiry, France.

A3GFP plasmid was derived from A3-LacZ construct ([@ref-24]) after replacement of the *lacZ* gene sequence with the corresponding *gfp* one (thanks to F.X. Jousset, INRA).

Linear molecules were obtained after proper restriction of 10 μg of JcDV-based pFull, pNS and pVP vectors. DNA was cut as indicated in [Fig. 1](#fig-1){ref-type="fig"} with restriction enzymes *Cla*I, *Pvu*II, *Xcm*I, *Afl*II, *Msp*A1L and *Psh*AI according to the New England Biolabs protocols. *Cla*I and *Pvu*II cut 163 nucleotides upstream JcDV's right ITR and 333 nucleotides upstream left ITR, respectively in the pBR322 plasmid backbone whereas *Xcm*I cuts eight nucleotides upstream the p93 TATA box. *Afl*II restriction site deleted the polyadenylation signals (poly-A) which belong to both ORF1 and ORF2/ORF3 in the ambisense organization of JcDV and *Msp*A1L and *Psh*AI cut within right and left ITRs at positions 526/5506 and 88/5944, respectively according to the nts numbers in the virus sequence. Restricted DNA was separated on a 0.8% agarose gel and expected bands were cut out from the gel (NucleoSpin® Extract II kit; Macherey-Nagel, Düren, Germany). Restricted DNA size and purity were assessed following conventional protocols.

![Schematic organization of JcDV-based plasmids used to generate linear sequences for transfection experiments.\
pBR322 backbone is figured as dotted gray line. JcDV structural proteins (*VP*) coding sequences are represented by a solid black line; non-structural proteins (*NS*) genes by a solid gray line. Both share a polyadenylation signal shown as an open ellipse. Open boxes figure the p9 and p93 ITRs, hatched boxes underline the location of p9 and p93 promoters, respectively. GFP coding sequence is figured with a gray box and its 3′ SV40-derived polyadenylation signal is shown as a hatched line. Arrows numbered according to [Table 1](#table-1){ref-type="table"} figure the primers used for PCR-based experiments. Primers used for walk-PCR are represented above; primers 7--13 represented only relatively to p9 can also hybridize to p93 DNA sequences when present. Gray-filled arrowheads figure restriction sites used to generate linear molecules from the plasmid constructs. Open arrowheads figure restriction sites used for walk-PCR experiments. Subscript numbers indicate iterated restriction sites. By convention, nucleotide numbers of each linear molecule are accorded to the 5′ C generated after *Cla*I restriction (AT/CGAT). Restriction enzymes are: A: *Afl*II, C: *Cla*I, D: *Dra*I, H: *Hpa*I, M: *Msp*A1L, S: *Ssp*I, P: *Psh*AI, Pv: *Pvu*II, X: *Xcm*I, respectively. Linear molecules were obtained after restriction of three different JcDV-based vectors. Their length is indicated under the name of each plasmid: (A) pFull encompassing a full-length sequence of JcDV DNA and the GFP marker gene, cloned into pBR322 plasmid. This schematic representation displays all the symbols described above; some of them only are reported in B and C. (B) pVP in comparison to pFull, a frameshift deletion affects the *NS* region (C) pNS in comparison to pFull, lacks VP genes. The expression of GFP is directly under the control of the p9 promoter. Primers giving rise to specific products after PCR are shown (See [Table 1](#table-1){ref-type="table"}).](peerj-06-4860-g001){#fig-1}

Cell culture and transfection system
------------------------------------

*Sf9* cells (ATCC CRL 1711) derived from *S. frugiperda* ovaries ([@ref-35]) and IPLB-Ld652 cells derived from *Lymantria dispar* ovaries ([@ref-40]) were maintained at 28 °C in 10% heat-inactivated fetal calf serum (FCS) supplemented TC100 medium.

A total of 1 μg of DNA was used for the transfection of 2.10^4^ *Sf9* cells with Jet PEI (Polyplus-Transfection, Illkirch, France) according to the manufacturer's protocol.

The number of GFP expressing cells, among 10,000 sorted live cells, was measured via fluorescent activated cell sorter (BD FACSCalibur; BD Niosciences, Le Pont de Claix, France) at 488 nm excitation and 530 nm emission. Microscopy was performed with a Nikon MICROPHOT-FXA microscope /ACT-2U software (Nikon, Tokyo, Japan).

Fluorescent colonies were picked out then amplified to confluence in *Sf9*-conditioned TC100 medium supplemented with 20% heat-inactivated FCS. Each amplified clonal cell population was diluted and subcloned three times before populations stably expressing GFP were obtained (approximately two clones *per* initial transfection).

DNA analysis
------------

Low molecular weight DNA was extracted according to [@ref-38]. For genomic DNA analysis, 30 μg of DNA were extracted using standard protocols and restricted with 150 U of the appropriate restriction enzymes. All the restriction enzymes were from New England Biolabs. Restricted DNA was separated on a 0.8% agarose gel and bands were cut out from the gel (NucleoSpin® Extract II kit; Macherey-Nagel, Düren, Germany). Size and purity of each DNA fragment were assessed electrophoretically. Digested DNA were prepared for Southern blotting analysis according to conventional methods ([@ref-31]). Blots were then probed with a full length (pFull restricted with *Psh*AI) probe, either Dig-labelled for episomal DNA analysis, or ΔdCT^32^P-labelled for Southern blot analysis. Hybridizations were performed according to the respective manufacturer's protocols. Radioactive membrane was exposed on a storage phosphor screen and visualized using a Phosphor Imager STORM 840 after two or five days.

Statistical analysis
--------------------

The percentage of GFP expressing cells from five different measurements at three, six, 10, 18 and 30 days post-transfection (p.t.) was measured. The evolution of the GFP positive cells percentage along with time was represented with a linear correlation curve (*R*^2^ \> 0.5) and graphically compared. In addition, a Wilcoxon rank sum test with continuity correction (R suite; [@ref-42]) to the raw fluorescent cells number obtained after transfection of plasmid *vs.* linear JcDV-based vectors at four time points (6, 10, 18 and 30 d., p.t.).

Significance of differences in luciferase expression was assessed by a Student test (R suite; [@ref-42]).

PCR and RT-PCR
--------------

A total of 100 ng of DNA from each analyzed cell clone was used as a template for direct PCR (see [Table 1](#table-1){ref-type="table"}; [Fig. 1](#fig-1){ref-type="fig"} for primers names, sequences and positions). The *VP*-GFP fusion was assessed with primers located in the *VP1* (1) and in the C-terminus *VP* sequence (2) downstream the *gfp* gene. The right ITR (p9 ITR)-GFP region was examined in clones transfected with pNS-based molecules, using primers located in the p9 ITR (1′) and the *gfp* gene (2′). The NS-GFP region was amplified with primers based in the *gfp* (3) and *NS-3* genes (4). The long p9 ITR-*NS* region was assessed with primers located in the p9 ITR (1′) and the *NS-3* (4), using a long range/high fidelity amplification DNA polymerase (Herculase; Stratagene Agilent Technologies, Les Ulis, France).
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###### Primers used in PCR, RT-PCR, reverse PCR and walk PCR analysis.

![](peerj-06-4860-g008)

  ---------------------------------------------------------------------------------------------------------
  Analysis                               Primer       Sequence
  -------------------------------------- ------------ -----------------------------------------------------
  PCR (VP-GFP)                           **1**\       5′-TAGTCAGTATGTCTTTCTACACGGC-3′\
                                         **2**        5′-AACGGTGGTTTAATTAAACCC-3′

  PCR (ITR-GFP)                          **1′**\      5′-GTGACCTCGTTTGACCGGC-3′\
                                         **2′**       5′-GCTGAACTTGTGGCCGTTTAC-3′

  PCR (NS-GFP)                           **3**\       5′-GCATGGACGAGCTGTACAAG-3′\
                                         **4**        5′-GTTTCTTTGTGTTCGTCGTTTATTTG-3′

  RT-PCR (NS)                            **5**\       5′-CGTCCAAACATTGATCACGGAGCTG-3′\
                                         **6**        5′-GTAGTGTTGTGCAAAAGTGGTTCCAGA-3′

  Reverse PCR                            **11**       5′-GGTCAAACGAGGTCACAATAACAAGA-3′

  WalkPCR(Adaptor sequences)             **ADPR1**\   5′-CTAATACGACTCACTATAGGGCTCGAGCGGCCGCCCGGGGAGGT-3′\
                                         **ADPR2**    5′ P-ACCTCCCC-3′NH2

  (Adaptor primers)                      **AP1**\     5′-GGATCCTAATACGACTCACTATAGGGC-3′\
                                         **AP2**      5′-CTATAGGGCTCGAGCGGC-3′

  (P9-ITR region)                        **13**\      5′-CTGTTTTGCACACGGCCCAG-3′\
                                         **12**       5′-CCAGCCTCGACGCGAGTTTG-3′

  (ITR region)                           **10**\      5′-GCCGGTCAAACGAGGTCAC-3′\
                                         **9**\       5′-GCTATCTCGCTCTAACAGTTGC-3′\
                                         **8**\       5′-CTCGCACACTATTGCTGTCCTTC-3′\
                                         **7**        5′-CAGCTCCAAGGTCTTCGGATC-3′

  (VP1 region)                           **15**\      5′-CCAAGTTCAATATCTTCAGTAGCAGTAC-3′\
                                         **14**\      5′-GATGTATTAACCCGGCCGTGTA-3′\
                                         **19**       5′-CCTATGATTCCCACTGCTACTAGT-3′

  (GFP region)(NS3 region)(UTR region)   **16**\      5′-GCAGCTTATAATGGTTACAAATAAAGC-3′\
                                         **17**\      5′-CAAATAAACGACGAACACAAAGAAAC-3′\
                                         **18**       5′-TCACTGAGATGTTCACTCGAC-3′
  ---------------------------------------------------------------------------------------------------------

Total RNA was extracted from cells (NucleoSpin RNA II kit; Macherey-Nagel, Düren, Germany). The retrotranscription of mRNA was performed using the ThermoScript RT-PCR System kit (Invitrogen, Courtaboeuf, France). Amplification of the NS transcripts from the cDNA templates was performed using primers located in the *NS-1* (5) and the untranslated region 5′ to *NS-3* (6).

PCR were performed on a GeneAmp PCR system 2700; Applied Biosystems, Illkirch, France, using conditions adapted to the melting temperatures of the primers and expected sizes elongations.

Reverse PCR and walk PCR
------------------------

Reverse PCR was performed according to [@ref-28]. Briefly, 10 μg of cellular DNA was digested with *Hpa*I O/N at 37 °C and ligated O/N at 4 °C (T4 DNA ligase kit; Promega, Madison, WI, USA). PCR was performed on the circularized DNA with primers located in the *VP1* (14)/*gfp* (3), for lpFull and lpVP clones and in right ITR (11)/*gfp* (3) for lpNS clones lacking *VP* sequences. PCR products were run on a 0.8% agarose gel, purified (NucleoSpin Extract II kit, Macherey-Nagel, Düren, Germany) and sent for sequencing to the service provider (Genome express; see [Table 1](#table-1){ref-type="table"}; [Fig. 1](#fig-1){ref-type="fig"} for primers names, sequences and positions).

For walk PCR assays, genomic DNA from GFP+ clones was digested with either *Ssp*I, *Hpa*I or *Dra*I (several restriction sites in the viral sequence) or *Ava*I or *Eco*RV (non-cutter enzymes). A specific double-stranded adaptor with cohesive ends ADPR1/ADPR2 was allowed to hybridize before ligation O/N at 37 °C (T4 DNA ligase kit; Promega, Madison, WI, USA) at each extremity of the previously restricted DNA fragments. Then, nested PCRs were performed according to [@ref-30]. A set of nested primers located in the ITR sequence was designed (7, 8, 9, 10, 12 and 13) and two nested primers were selected in the adaptor sequence (AP1, AP2). Each adaptor-ligated fragment was submitted to a series of primary and nested amplifications. *Eco*RV or *Ava*I restricted genomic fragments were submitted to ligation and amplification as described above. For walk PCR analysis, two overlapping primers located in the *VP1* sequence (14 and 15) or in the *gfp* (three and 16) or in the *NS-3*/UTR (17, 18), were used to combine with AP1 and AP2 primers. PCR products were purified and sent for sequencing as above.

Data mining
-----------

Raw sequences from the amplified fragments were compared to each other, assembled using Cap 3 (<http://doua.prabi.fr/software/cap3>) when necessary and submitted for comparison to public databanks NCBI (<http://www.ncbi.nlm.nih.gov/BLAST/>) ([@ref-3]),SPODOBASE (<http://bioweb.ensam.inra.fr/spodobase/>) andLepido DB (<http://bipaa.genouest.org/blast/sfru/#>) and aligned against the JcDV, isolate Oxford (GenBank: [KC883978.1](KC883978.1)) using the Megablast conditions for viral sequences and the blastn conditions for the genomic ones. Only the results obtained with an expected value \> 10e5 are taken into consideration.

Results and Discussion
======================

JcDV-based linear vectors drive stable expression of GFP in *Sf9* cell lines
----------------------------------------------------------------------------

pFull (pJGFPH), pVP (pJGFPΔNSH) and pNS (pHp9GFPNSH) circular plasmids were used as positive controls for transfection and GFP expression in *Sf9* cells. The same plasmids were properly restricted to generate linear molecules encompassing different regions of the viral sequences and the *gfp* as a marker gene ([Fig. 1](#fig-1){ref-type="fig"}).

After transfection, expression and accumulation of GFP were monitored under microscopic examination up to six days p.t. then the percentage of GFP positive cells (GFP+) was estimated by visual counting of three different fields (∼100 cells).

An unrelated control, devoid of JcDV sequences, consisted of plasmid A3GFP which contains the *gfp* under the control of late actin A3 ubiquitous promoter of *Bombyx mori*. Transfection of both circular and linearized A3GFP molecules gave rise to a small, rapidly decreasing number of fluorescent cells which was undetectable one day p.t.. Although GFP+ cells appeared 48 h p.t. using circular plasmids, their relative number decreased along with time in agreement with previous observations ([@ref-7]). Surprisingly, for most linearized molecules, appearance of GFP+ cells showed a delay before reaching at 6 d. p.t. percentages equivalent to those obtained with circular molecules.

Complete deletion of both right- and left-ITRs (p9 and p93 ITR, respectively, *Msp*A1L) gave rise to rare GFP positive cells which persisted after one month in culture. The resulting expression of GFP can be related to the integration of transfected molecules in a transcribed genomic region.

When pFull, pVP and pNS were restricted with *Cla*I + *Afl*II the GFP+ cell number decreased dramatically. Since the *Cla*I cutting site, located in the pBR322 backbone, is used to generate every linear molecule, this effect is probably due to the *Afl*II cutting site which was brought along with the *gfp* gene during the construction of plasmids. Restriction with *Afl*II deleted the polyadenylation signals (poly-A) which belong to both ORF1 and ORF2/ORF3 in the ambisense organization of JcDV ([@ref-15]; [@ref-32]) and are present in all three constructs. This result is in agreement with the pivotal role of Polycomb Response Elements in this region, as described by [@ref-32].

We subsequently chose three linear molecules allowing high transformation efficiency, for further comparison with the corresponding circular plasmids.

pFull as well as pVP, were digested with *Cla*I + *Pvu*II which deleted the pBR322 plasmid backbone. lpFull expresses either NS proteins and VP-GFP proteins; lpVP exhibits a deletion within *NS* sequences.

pNS was linearized with *Cla*I + *Xcm*I to obtain the lpNS encompassing the p9 ITR, *gfp* and the *NS* sequences, but not the *VP* ones. Noticeably, deletion of the p93 ITR (*Cla*I + *Xcm*I restrictions) seemed not to affect the percentage of cells in which GFP accumulates. *Xcm*I cuts a few nucleotides upstream the p93 TATA box and still allows expression of ORF2 ORF3 and ORF4 (see below).

In each pair of linear molecules and circular corresponding ones, the *gfp* marker gene is expressed, either as a VP-GFP fusion protein (pFull, lpFull; pVP, lpVP) or under the direct control of the p9 capsid protein promoter (pNS, lpNS) ([Fig. 1](#fig-1){ref-type="fig"}).

*Sf9* cells were transfected in parallel with pFull/lpFull, pVP/lpVP and pNS/lpNS. The percentage of GFP-fluorescent cells was followed as a function of time p.t.. The results, shown in [Fig. 2](#fig-2){ref-type="fig"}, of three to six independent experiments, allowed the establishment of linear regression profiles of the GFP+ cells percentages, at 3, 6, 10, 18 and 30 d. p.t.. All linear constructs gave significant GFP expression starting six days p.t.. Transfection of lpFull gave rise to an increasing number of GFP+ cells over the next 20 days to finally reach, at 30 days p.t., a 10% plateau. lpVP transfection gave rise to an increasing number of GFP+ cells reaching 11% at 30 days p.t.. The lpNS construct allows the obtention of 4% GFP+ cells at 30 days p.t.. As expected, VP-GFP expression was visible as a bright punctate staining in the nucleus of lpFull and lpVP transfected cells ([Fig. 3A](#fig-3){ref-type="fig"}) although pNS circular and linear molecules gave rise to a cell widespread GFP expression ([Fig. 3B](#fig-3){ref-type="fig"}). A scheme of individual cell populations obtained after three cloning rounds is shown in [Fig. 3C](#fig-3){ref-type="fig"}.

![Relative enrichment of GFP+ cells along with growth of transfected *Sf*9 cells.\
Following transfection of *Sf9* cells using Jet PEI and indicated DNA molecules, GFP expression was measured in cell populations three days, 6 d., 10 d., 18 d. and 30 d. post-transfection (p.t.) by flow cytometry. The percentage of GFP+ cells was measured in three to five independent experiments and the results are reported on each coordinates. Linear regression curves can be drawn which show the evolution of GFP+ cells percentages along time (*R*^2^ \> 0.5). *a*, non significative; *b*, *p* \< 0.05; *c*, *p* \< 0.01 (Wilcoxon rank sum test with continuity correction, R suite; [@ref-42]).](peerj-06-4860-g002){#fig-2}

![Cellular clones showing persistent expression of GFP after transfection with JcDV-based linear molecules.\
(A) Typical clump of cells transfected with lpFull or lpVP and showing mainly nuclear localization of the GFP fluorescence. (B) Widespread cytoplasmic fluorescence in lpNS transfected cells. (C) Isolation scheme of clonal cell populations from clumps exemplified in A and B. Numbers between brackets are the percentage of fluorescent cells in each clone as measured by cytometry. Several stable fluorescent cell clones were recovered and designated lpX-n1Yn2, "l" is for linearized, "pX" for the plasmid origin of the molecule and the combination "n1Yn2" depicts the steps of clonal population isolation.](peerj-06-4860-g003){#fig-3}

Along with cellular divisions, the percentage of GFP-positive cells increased in cells transfected with linear molecules to reach, 30 days p.t., an amount three to four times higher than in cells transfected with circular constructs. It could be hypothesized that early integration events are "stabilized" along with time, meaning that the *gfp* expression becomes more efficient when the p9 promoter is surrounded with a favorable molecular environment, for instance after integration in the chromosomal DNA of the host cell. It is also possible that the p9 promoter activity is regulated along time after integration. The latter possibility is further explored below.

Stable GFP-expressing cell clones from both circular and linear molecules transfection were obtained, but only lpFull, lpVP and lpNS transfected cells were used to generate sub-clones derived from a single transfected cell. It is to be noted that along with the cloning processes, GFP expression decline was observed in 10% of clones due to *gfp* gene loss as revealed by PCR (not shown). From the rapidly growing cloned populations which were retained for further studies, all exhibited a sustained expression of GFP and were evaluated *circa* 90% GFP+ 12 months after cloning (FACS measurement, not shown).

JcDV sequences drive integration of vectorized DNA sequences in *Sf9* transfected cells
---------------------------------------------------------------------------------------

To investigate the presence of episomal forms of transfected linear JcDV DNA-based molecules, low-molecular weight DNA from several stable cell clones (lpFull-3f2, lpFull-4a1, lpNS-6f1, lpNS-6f2 lpVP-9f3 and lpVP-9f4) was analyzed by Southern blotting ([Fig. 4A](#fig-4){ref-type="fig"}). No signal was detected when probing with a DIG-labeled linearized JcDV probe suggesting that episomal forms were not detected in the tested clones nor remnant unintegrated linear molecules persisted in the clones.

![Integration patterns are dependent on transfected viral sequences.\
(A) Low molecular weight (LMW) DNA was extracted from two different stable subclones per linear construct and hybridized with a DIG-labelled probe. pB, pVP and pFull represent pBRJH ([@ref-15]), pVP and pFull native plasmids, respectively. *Sf9*h, pBh, pVPh and pHh indicate LMW DNA extracted from mock-transfected, pB, pVP and pFull transfected *Sf9* cells, respectively. (B) Genomic DNA was isolated from stable fluorescent cell sub-clones, restricted with either *Ava*I (A) or *Ava*I + *Hpa*I (A + H) and separated electrophoretically. Hybridization was performed using a radioactively labeled probe. pFull plasmid and the subsequent linearized lpFull are used as positive control. *Sf9* DNA was used as a negative control.](peerj-06-4860-g004){#fig-4}

To check for integration events, DNA extracted from sub-cloned cell populations, were subjected to Southern Blot analysis ([Fig. 4B](#fig-4){ref-type="fig"}). Genomic DNA was obtained, digested with either *Ava*I, or *Ava*I and *Hpa*I, the latter cutting twice within lpFull and lpVP transgene sequences and once in lpNS molecules (*Ava*I does not cut within the transgene sequences, see [Fig. 1](#fig-1){ref-type="fig"}). Restricted DNA was hybridized with a full-length ^32^P-labelled JcDV probe.

lpFull clones (lpFull-3f2, lpFull-4a1) DNA, digested with *Ava*I and hybridized to the probe, showed a single band at 12 kbp and 11 kbp respectively, larger than the 7.5 kbp lpFull transfected construct. Integration events in clones lpFull-3f2 and lpFull-4a1 thus occurred at a single but different site in each clone. After double-restriction with *Ava*I and *Hpa*I, one smaller band is generated from the DNA of either lpFull-3f2 (5.5 kbp) or lpFull-4a1 clone (7 kbp). In the latter restriction, each of both obtained bands is larger than the 3 kbp restricted lpFull transgene sequence suggesting different integration sites in the two clones. These data suggest that lpFull sequence integration into lepidopteran cell line *Sf9* was systematically associated with rearrangements.

DNA from the lpVP-9f3 clone (lacking *NS* genes), restricted with *Ava*I and Southern-blotted, showed two large bands at 13 kbp and 15 kbp larger than the 6.7 kbp lpVP transfected DNA suggesting more than one integration site. The analysis of lpVP-9f3 clone after restriction with *Ava*I and *Hpa*I, shows at least six bands at 2.6, 2.8, 5.0, 6.0, 9.0 and 11 kbp smaller or larger than the 3 kbp restricted lpVP transgene sequences. Once again, this indicates that the transfected linear molecules underwent drastic modifications during or after integration in the recipient cell genome. Altogether, the presence of several bands suggests that viral sequences are integrated at different sites into *Sf9* genome.

Consistent with previous observations after transfection of circular plasmid molecules ([@ref-7]), lpFull, which is supposed to retain the capacity of coding NS proteins, gave rise to an apparent small number of integrated molecules. This could be interpreted as a single integration event whereas the analysis of clones obtained after lpVP transfection (modified *NS* genes) evoked possible multiple integration sites. We could not confirm concatemeric integration ([@ref-7]).

Hybridization of the lpNS-6f2 clone DNA, after digestion with *Ava*I, revealed four bands estimated larger than 15 kbp and, at least, two additional bands between 10 and 15 kbp, which are much larger than the 4.1 kbp of the linear lpNS transfected sequence. It is to be noted that the hybridization signal is much more intense than that observed with lpFull- and lpVP-clones, for the same amount of total DNA. This could suggest that more integration events occurred when using lpNS molecules for transfection.

After digestion with *Ava*I and *Hpa*I, lpNS-6f2 hybridization profile shows a 2.6 kbp band and 10 additional bands ranging from 2.2 kbp to 12 kbp. The revealed bands are all larger than the 2 kbp and 3 kbp lpNS restricted transfected sequences. Linear viral sequences also could probably be heavily rearranged after integration in numerous different sites.

To further investigate the organization of integrated viral sequences into *Sf9* genome, PCR and RT-PCR amplifications were performed on the DNA extracted from GFP+ cell clones.

Integrated JcDV-derived sequences are rearranged
------------------------------------------------

Primers ([Table 1](#table-1){ref-type="table"}) were designed to detect two major viral target regions: the *VP-gfp* and the *gfp-NS* sequences ([Fig. 1](#fig-1){ref-type="fig"}). Additional primers (1′, 4; cf. [Fig. 1](#fig-1){ref-type="fig"}) were used to amplify a larger DNA fragment between the p9 ITR and the *NS* region.

In order to assess the presence of *NS* and *VP* sequences in transfected clones, DNA from a selection of representative clones for each transfection was subjected to PCR analysis. The 3 kbp *VP-gfp* (1, 2) region was successfully amplified from the cellular DNA of all lpFull (lpFull-3f2, lpFull-4a1) and lpVP (lpVP-9f3, lpVP-9f4) subclones, thus demonstrating that at least one copy of this region remains unaffected after integration ([Fig. 5A](#fig-5){ref-type="fig"}). However, several unexpected amplified bands indicate that rearranged copies of this large molecular region are also present within the integrated JcDV-derived sequences in lpVP clones.

![NS genes sequences are highly rearranged in stable fluorescent cell clones.\
(A) PCR amplification of the *VP*-GFP region with primers one and two (see [Table 1](#table-1){ref-type="table"}; [Fig. 1](#fig-1){ref-type="fig"}) from lpFull and lpVP clones. (B) Amplification of the large p9 ITR-*NS* region using primers pair 1′, 4. (C) Amplification of the *NS*-GFP region using primers pair 3, 4. (D) Amplification of ORF2, ORF3 and ORF4 RNA transcripts by RT-PCR using primers in the untranslated region (UTR) upstream the NS-3 ATG codon and the NS-1 region (see [Table 1](#table-1){ref-type="table"}). Molecular weight marker (Mk) band sizes are shown on each gel. pFull was used as positive control. *Sf9* DNA was used as a negative control.](peerj-06-4860-g005){#fig-5}

Using primers 1′ and 4, the expected p9 ITR-NS 3.4 kbp fragment is amplified from clone lpNS-6f2 DNA only ([Fig. 5B](#fig-5){ref-type="fig"}). lpFull-3f2 and lpVP-9f3 DNA did not support the amplification of the expected 6 kbp and 5.1 kbp fragments respectively ([Fig. 5B](#fig-5){ref-type="fig"}). Since lpVP-9f3 and lpFull-3f2 DNA gave rise to the amplification of 3.2 kbp and 3 kbp fragments respectively, the target DNA is likely to be affected by large deletions.

This was confirmed since *NS-gfp* region amplification (primers 3/4, [Fig. 1](#fig-1){ref-type="fig"}) generated smaller bands than expected from the cellular DNA of lpFull-3f2 and lpFull-4a1 clones (expected band: 3.7 kbp, amplified: 0.4 kbp) and in lpVP-9f3 and lpVP-9f4 clones (expected band: 3 kbp, amplified: 1 kbp). Furthermore, in lpNS-6f1 and lpNS-6f2 clones, the expected 2.6 kbp band was properly amplified as well as an additional band at 2 kbp ([Fig. 5C](#fig-5){ref-type="fig"}). These data show that at least one complete *NS-gfp* sequence is present within the genome of the lpNS transfected clones, whereas lpFull and lpVP DNAs do not support PCR amplification of this region.

Altogether, these results suggest that all lpFull, lpNS and lpVP clones, which were recovered and amplified, contain at least one copy each of a *VP*- or p9-*gfp* sequence stably integrated within the *Sf9* genome whereas the repeated failure to amplify *NS* gene sequences from lpFull and lpVP clones indicate that major modifications, probably deletions, has occurred in this region along with the integration and/or cell cloning process. Only in lpNS clones one copy of the p93 ITR-NS region remained intact after integration.

In order to verify that the full *NS* copy could be functionally expressed, total mRNA was extracted from all stable clones and tested by RT-PCR for VP-GFP fusion transcripts as well as for NS transcription ([Fig. 5D](#fig-5){ref-type="fig"}). Even if the RT kit involves a DNAse step, the RNA samples were verified DNA free according to direct PCR (not shown).

As expected, VP-GFP fusion mRNA, was successfully retrotranscribed then PCR-amplified in all lpFull, lpVP and lpNS clones (data not shown).

Only the mRNA extracted from lpNS-6f2 cells and subjected to RT-PCR amplification of the UTR-NS-1 region, gave rise to amplification of both the expected 400 bp (spliced form) ([@ref-1]) and 1,080 bp (unspliced form) bands, indicating that the 2.4 kb and 1.7 kb NS transcripts can be expressed in lpNS clones. An additional 800 bp band suggests that an unidentified mRNA transcript is also expressed from one of the numerous integrated JcDV-based sequences after transfection of *Sf9* cells with lpNS molecules.

Attempts to amplify the 400 bp and/or the 1,080 bp band failed with cDNA obtained from lpFull and lpVP clones ([Fig. 5D](#fig-5){ref-type="fig"}).

Rearranged viral regions are interspersed with non-viral sequences in transfected *Sf9* cells
---------------------------------------------------------------------------------------------

In order to, identify and characterize more precisely the rearrangement pattern as well as some of the junctions between integrated virus-based molecules and cellular *Sf9* DNA, stable fluorescent clones resulting from lpFull, lpNS and lpVP transfections were analyzed using reverse PCR ([@ref-28]) and walk-PCR ([@ref-30]). Each DNA sequence obtained after reverse- or walk-PCR was verified, by direct amplification of the cellular DNA extracted from JcDV-transfected clones, to generate a properly sized band (not shown). The raw sequences are presented in a .fasta format in [Supplemental Information](#supplemental-information){ref-type="supplementary-material"} and [Figs. 6A](#fig-6){ref-type="fig"}--[6C](#fig-6){ref-type="fig"} summarize the global repartition of "scrambled" viral integrated sequences according to their respective positions in transfected constructs.

![Schematic representation of viral and genomic DNA sequences identified in our experiments.\
Raw sequences obtained after numerous amplifications of viral-genomic junctions ([Supplemental Information](#supplemental-information){ref-type="supplementary-material"}) where aligned against (i) the sequence of the transfected linear plasmid using the discontiguous megablast conditions, (ii) the nr/nt nucleotide collection specified to *Spodoptera frugiperda* (taxid 7108), using the blastn conditions. Only the cleaned sequences are represented and motifs identify contiguous sequences from the same amplified sequence, named on the right. (A) BLAST-based alignment against lpFull of raw sequences obtained after amplifications of viral junctions from lpFull-transfected cells. The open diamond represents the location of ∼20 nts from the Bac 68E14 from *S. frugiperda* \[id:681381.1\] as a significative example of the rearrangement. (B) BLAST-based alignment against lpVP of raw sequences obtained after amplifications of viral junctions from lpVP-transfected cells. The triangle represents 70 nts of BAC 75E05 from *S. frugiperda* \[id: 681368.1\] flanking a 40 nts fragment of the ITR (2--40) and the ellipse represents 70 nts of the same BAC intercalated between a JcDV *VP* fragment (3,829--3,531) and the *NS*-ITR boundary (771--551). (C) BLAST alignment against lpNS of raw sequences obtained after amplifications of viral junctions from lpNS-transfected cells.](peerj-06-4860-g006){#fig-6}

Briefly, the isolation of sequences containing mainly rearranged viral sequences is the signature of a dense recombination activity of cellular origin.

We repeatedly found, and verified, roughly the same viral rearrangement in each of the analyzed lpFull subclones ([Fig. 6A](#fig-6){ref-type="fig"}) bringing together a *NS-1/NS-2* fragment and a *VP4* fragment, otherwise distant of ∼700 nucleotides in the originally transfected molecule, and placed in opposite orientations. Noteworthy, the considered *VP4* fragment lies in the 3′ VP coding sequence which was displaced from the *VP* gene by the *gfp* insertion. Both went close to the p9 ITR. We also found molecules joining the same *NS* sequence with the same ITR nucleotides, without *VP* sequences. The integration situation thus seems to be rather simple in lpFull clones since only one rearrangement, was characterized from the different clones tested which are unlikely to be issued from the same transfected cell, even if we cannot exclude this possibility. Two non-viral sequences were identified interspersed with viral sequences (see below).

Five different lpVP clones and sub-clones were analyzed by walk-PCR and/or by reverse PCR ([Fig. 6B](#fig-6){ref-type="fig"}). Two different sequences, shared by all the lpVP subclones and two clone-specific rearrangements were analyzed. All these sequences show the involvement of ITRs sequence fragments rearranged with *NS* and/or *VP* sequences fragments issued undoubtedly from the transfected linear vector. Among the few non-viral DNA sequences interspersed within the rearrangements, two were large enough to deserve identification (see below).

lpNS integrants are diverse in number, size and composition ([Fig. 6C](#fig-6){ref-type="fig"}). They involve either ITR or ITR/NS sequences. Non-viral sequences, too short to be identified, alternate with vector-derived sequences, viral or not (*gfp*, pBR322, other).

Non-viral sequences are interspersed with viral ones in the rearrangements
--------------------------------------------------------------------------

The recent publication of two *Spodoptera frugiperda* genomes ([@ref-17]) enriched the data base with pertinent sequences. All the non-viral sequences were compared to each other and to online databases NCBI (<http://www.ncbi.nlm.nih.gov/BLAST/>) ([@ref-3]), SPODOBASE (<http://bioweb.ensam.inra.fr/spodobase/>) and Lepido DB (<http://bipaa.genouest.org/blast/sfru/#>) with an expected value \> 10e5.

[Figs. 6A](#fig-6){ref-type="fig"}--[6C](#fig-6){ref-type="fig"} schematizes the location of cleaned viral sequences along the sequences of the transfected linear molecules, lpFull, lpVP and lpNS, respectively. No non-viral sequence (or not present in the transfected molecules) was identified in the lpNS rearrangements. Non-viral and unidentified sequences were found in the lpVP and lpFull rearrangements.

The sequence identified as "lpVP_1" as well as the sequence "lpVP_1/1" in [Supplemental Information](#supplemental-information){ref-type="supplementary-material"} matched with numerous genomic sequences, best matches being with "*Spodoptera frugiperda* 41I04_SfBAC" \[id: FP3404412.1\] and "*Spodoptera frugiperda* 75E05_SfBAC" \[id: FO681368.1\].

The sequences identified as "lpFull_AP2/6a," "lpFull_AP2/1a" and "lpFull_12/1" in the [Supplemental Information](#supplemental-information){ref-type="supplementary-material"} match mainly with the "*Spodoptera frugiperda* sequence from bacterial artificial chromosome (BAC) clone 68E14" (GenBank: [FO681381.1](FO681381.1)). Since these viral and cellular sequences are heavily modified and interspersed with unidentified small DNA sequences, we preferred to schematize their location in [Fig. 6](#fig-6){ref-type="fig"}.

Last, the sequence identified as "lpFull_AP2/16a" in the [Supplemental Information](#supplemental-information){ref-type="supplementary-material"} matches mainly with the "*Spodoptera frugiperda*" cell-line *Sf9* ribosomal genes its1 and its2 (GenBank: [Q478352.1](Q478352.1)). Note that in this case 63 nts of genomic sequence (1,326--1,389) overlap with 26 nts of viral sequences from the ITRs (2--28, 5,904--5,930), we cannot claim that it is a true junction.

Sequences "lpFull_AP2/7" and "lpFull_AP2/6b" exhibit also genomic sequences but the viral moiety of these sequences is too tiny to deserve mention. The BACs have been extensively described ([@ref-10], [@ref-11]), and, according to their organization, the sequences evoked before could pertain to highly repetitive, non-coding and intergenic regions. Using a preliminary version of TE annotation of the "*Sf* corn strain genome assembly" ([@ref-17]), we found that, indeed, all the characterized flanking sequences are located in intergenic regions and/or different TE sequences which remain to be identified. Incidentally, the previously described flanking sequences of the circular vectors ([@ref-7]) were also found located in intergenic and TE regions. However *Sf* genomic and transcriptomic data are currently insufficient to sustain the hypothesis of genomic rearrangements induced by JcDV integration *vs.* genomic sequences with identities to viral sequences as already evoked ([@ref-23]), whatever the cause.

NS proteins do not transactivate the p9 promoter
------------------------------------------------

Considering only the results obtained with lpFull and lpVP clones, we seem to corroborate previous conclusions, *i.e.*, in the presence of *NS* genes, integration of JcDV-derived sequences integrate within the host-cell genome at a low, probably single copy number although deletion of *NS* genes allows multiple copies integration, even if we cannot provide evidence of concatemers generation and integration from linear pVP molecules. However, as evoked in the same work and as reported for non-structural proteins from *Parvovirinae* ([@ref-4]; [@ref-12]), a maintained expression of JcDV NS proteins may be harmful for the host cell and interfere with the cell cycle. Thus, it is not surprising to recover only cell clones having lost the capacity of NS expression after JcDV-based sequences integration. This is confirmed by the extensive rearrangements of NS coding sequences which rendered their expression unlikely. Moreover, a retrospective PCR amplification indicates that *NS* gene was already undetectable six days p.t. in lpFull-transfected cells (not shown). Similarly, cells transfected with pNS and lpNs have allowed the isolation of only some GFP+ clones ([Fig. 2](#fig-2){ref-type="fig"}). However, in the DNA extracted from lpNS cell clones, numerous rearranged viral sequences interspersed with DNA fragments from a different origin, are accompanied with a sustained expression of NS mRNA. This could be explained by an expression of the *NS* genes low enough not to perturb the cell cycle. Actually, the *Xcm*I restriction used to generate lpNS cuts the viral sequence between the p93 TATA box and the regulatory sequences ([@ref-15]) and this could account a reduced expression of p93 driven mRNA. Our results are concordant with recently published data showing that numerous genomes are interspersed with parvovirus-related sequences ([@ref-23]) or endogenous viral elements ([@ref-21]; [@ref-34]) often fragmented/rearranged.

Nevertheless, we were unable to explain two results: (i) the percentage of GFP expressing cells increases with time in all the clones ([Fig. 2](#fig-2){ref-type="fig"}), (ii) lpNS transformed cells seem to express GFP less stably and less efficiently than lpVP and lpFull transformed ones ([Fig. 3B](#fig-3){ref-type="fig"}). We thus explored in vitro the regulatory activities of NS proteins on the p9 promoter.

Three plasmid vectors were built to express NS-1, NS-2 and NS-3, respectively. A reporter plasmid was adapted to place the expression of *Luc* under the control of p9 promoter and IPLB-Ld652 permissive cells were co-transfected to perform a "luciferase" assay matched against the *Renilla luciferase* expression. [Fig. 7](#fig-7){ref-type="fig"} clearly indicates that NS-1 expression does not significantly affect p9 activity even if we cannot ascertain that a functional amount of NS1 is produced. This is not completely unexpected since JcDV NS-1 seems to lack the COOH-terminus transactivation-associated region ([@ref-22]; [@ref-27]; [@ref-37]). Transactivation of the p9 promoter is neither devoted to NS-2 or NS-3 which on the contrary down-regulate it at 96 h. In addition, it is clear that the "basal" activity of the p9 promoter augments along with time, in vitro also. So, it is no more surprising that integration of linear molecules expressing GFP under the control of the p9 promoter is accompanied with a growing number of "green" cells, probably due to the growing number of cells which become detectable along with time. Also, the limited number of GFP expressing cells, even 30 days post transfection of lpNS linear vector could be explained by the retained capacity of these cells to express the *NS* genes.

![JcDV NS proteins do not transactivate the p9 promoter in vitro.\
IPLB-Ld652 permissive cells were co-transfected with plasmid vectors expressing JcDV NS-1, NS-2 and NS-3, respectively and a reporter plasmid adapted to place the expression of the firefly luciferase gene under the control of p93 promoter. The assay was matched against the *renilla* luciferase stable expression. Firefly luciferase activity was measured as indicated in the "Material and Methods" section. Three independent experiments were performed and the significance of the results was assessed after a Student's test (R suite; [@ref-42]).](peerj-06-4860-g007){#fig-7}

In vivo, injection of JcDV-derived plasmids in insect syncytial embryo gives rise to a somatic transformation of some cells throughout the larval stages ([@ref-29]). However, the modification does not cross the barrier of the germ cells. It remains to go further on the way of insect transformation, using linear JcDV-derived molecules equipped with a right ITR to integrate efficiently, a strong promoter, JcDV p9 being a good candidate, and an insect-compatible polyadenylation signal. Non-structural protein(s) expression, although probably useful for original single integration profile, are probably involved also in the rearrangement of both viral and cellular genomes. The *Dependoparvovirus adeno-associated virus* type 2 (AAV2) genome is site specifically integrated after interaction of Rep (NS) proteins and cellular proteins mainly involved in DNA repair ([@ref-26]), including nonhomologous end joining proteins ([@ref-13]). Although the JcDV NS1 protein, as AAV2 Rep protein, recognizes and binds to a specific sequence of viral DNA ([@ref-14]), it does not seem capable of directing site-specifically the integration of the viral genome within the host genome. Cellular proteins could therefore be the major players in this integration. The fact that the flanking sequences are identified as "noncoding" may reflect spontaneous selection of cell clones least affected by the integration.

Conclusion
==========

We investigated the status of JcDV-based linear DNA molecules after transfection in non-permissive *Sf9* cells. Molecules harboring either complete JcDV sequences or ITRs and *vp*, *i.e.*, the linear equivalent to the plasmids reported in ([@ref-7]) or only p9-ITR and *ns*, the *gfp* being directly under the control of the p9 promoter, lead to GFP stable expression in transfected cells. However, JcDV sequence integration was systematically associated with major rearrangements (*scrambling*) even in the case of a possibly single integration event after transfection with complete JcDV-based molecule. Some genomic host-sequences were caught in the rearrangements and remain mostly unidentified even if some correspond to non-coding and repeated or transposable sequences. The lower number of cells expressing GFP in cells harboring a possible continuous expression of NS proteins as well as the obvious increase along with time of the number of GFP+ cells were intriguing. A luciferase assay of the NS-mediated regulation of the p9 promoter activity revealed that on the contrary to other *Parvoviridae*, NS-1 protein from JcDV seems not to transactivate the promoter driving the expression of structural proteins. In addition, NS-2 and NS-3 proteins down-regulate the p9 promoter late after transfection.

Altogether, it is possible to use JcDV-derived linear sequences, provided they harbor at least one ITR and poly-A signals, to direct the random integration of a reporter gene. The presence of *ns* genes could be facultative since integration seems mainly due to cellular factors.
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